Skip to main content
. 2023 Jun 23;45(1):2224888. doi: 10.1080/0886022X.2023.2224888

Table 4.

Renal function and in-hospital clinical outcomes.

  Patient #1 Patient #2 Patient #3 Patient #4 Patient #5 Patient #6 Patient #7 Patient #8 Patient #9 Patient #10
Death No No No No No No No No No No
Hospitalization length, days 4 13 3 4 4 18 6 12 4 5
Vascular complications No No No No No No No No No No
Bleeding complications No No No No No No No Yesa No No
Renal Function                    
 Baseline serum creatinine, md/dL 2.01 3.10 2.39 3.16 2.33 3.2 1.83 3.3 3.65 1.49
 Baseline creatinine clearance, mL/min 50.19 18.32 23.72 41.10 24.62 17.49 26.9 18.03 9.91 38.26
 Post imaging serum creatinine, md/dL 2.26 3.01 2.37 3.08 2.45 2.93 1.73 3.25 3.98 1.56
 Post imaging creatinine clearance, mL/min 44.64 18.87 23.92 42.16 23.41 19.16 31.49 18.36 9.16 36.54
 Post-TAVI* (at discharge) serum creatinine, mg/dL 2.24 4.00 2.27 2.37 1.71 2.34 1.62 4.01 2.54 1.46
 Post-TAVI*(at discharge) creatinine clearance, mL/min 45.04 14.2 24.97 55.26 33.54 23.91 33.44 14.84 14.24 39.04
 Need for dialysis No Yesb No No No No No No No No

*TAVI = Transcatheter aortic valve implantation.

aGastrointestinal bleeding associated with Clostridium difficile infection; VARC-3 type 1 of bleeding [12].

bUltrafiltration modality due to congestive symptoms after transcatheter aortic valve implantation.